The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts

Virology

Volumn 416, Issue 1-2, 2011, Pages 32-41

  Paglino, Justin ^a   Tattersall, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LuIII; Minute Virus of Mice (MVM); Oncolysis; Oncolytic; Parvovirus; QPCR; Stepwise transformation; Tropism; Virotherapy; VP2

Indexed keywords

ONCOLYTIC PARVOVIRUS;

ARTICLE; CELL KILLING; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOLYTIC VIROTHERAPY; PARVOVIRUS; PHENOTYPE; PRIORITY JOURNAL; VIROGENESIS; VIRUS CAPSID; VIRUS GENE;

CAPSID PROTEINS; CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; PARVOVIRUS;

MINUTE VIRUS OF MICE; MIRIDAE; PARVOVIRUS; RODENTIA;

EID: 79958076967     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.04.015     Document Type: Article

References (47)

1. Agbandje-McKenna M., Llamas-Saiz A.L., Wang F., Tattersall P., Rossmann M.G. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 1998, 6:1369-1381.
2. Arruda V.R., Xiao W. It's all about the clothing: capsid domination in the adeno-associated viral vector world. J. Thromb. Haemost. 2007, 5:12-15.
3. Ball-Goodrich L.J., Tattersall P. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J. Virol. 1992, 66:3415-3423.
4. Chen Y.Q., de Foresta F., Hertoghs J., Avalosse B.L., Cornelis J.J., Rommelaere J. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. Cancer Res. 1986, 46:3574-3579.
5. Chen Y.Q., Tuynder M.C., Cornelis J.J., Boukamp P., Fusenig N.E., Rommelaere J. Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic. Carcinogenesis 1989, 10:163-167.
6. Cornelis J.J., Salome N., Dinsart C., Rommelaere J. Vectors based on autonomous parvoviruses: Novel tools to treat cancer?. J. Gene Med. 2004, 6(Suppl 1):S193-S202.
7. Cotmore S.F., Tattersall P. In vivo resolution of circular plasmids containing concatemer junction fragments from minute virus of mice DNA and their subsequent replication as linear molecules. J. Virol. 1992, 66:420-431.
8. Cotmore S.F., Tattersall P. Genome packaging sense is controlled by the efficiency of the nick site in the right-end replication origin of parvoviruses minute virus of mice and LuIII. J. Virol. 2005, 79:2287-2300.
9. Dupont F. Risk assessment of the use of autonomous parvovirus-based vectors. Curr. Gene Ther. 2003, 3:567-582.
10. Dupont F., Avalosse B., Karim A., Mine N., Bosseler M., Maron A., Van den Broeke A., Ghanem G.E., Burny A., Zeicher M. Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector. Gene Ther. 2000, 7:790-796.
11. Dupressoir T., Vanacker J.M., Cornelis J.J., Duponchel N., Rommelaere J. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Res. 1989, 49:3203-3208.
12. Everts B., van der Poel H.G. Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther. 2005, 12:141-161.
13. Faisst S., Guittard D., Benner A., Cesbron J.Y., Schlehofer J.R., Rommelaere J., Dupressoir T. Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. Int. J. Cancer 1998, 75:584-589.
14. Farr G.A., Cotmore S.F., Tattersall P. VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J. Virol. 2006, 80:161-171.
15. Farr G.A., Tattersall P. A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection. Virology 2004, 323:243-256.
16. Farr G.A., Zhang L.G., Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17148-17153.
17. Gardiner E.M., Tattersall P. Evidence that developmentally regulated control of gene expression by a parvoviral allotropic determinant is particle mediated. J. Virol. 1988, 62:1713-1722.
18. Gardiner E.M., Tattersall P. Mapping of the fibrotropic and lymphotropic host range determinants of the parvovirus minute virus of mice. J. Virol. 1988, 62:2605-2613.
19. Garnick R.L. Experience with viral contamination in cell culture. Dev. Biol. Stand. 1996, 88:49-56.
20. Geletneky K., Kiprianova I., Ayache A., Koch R., Herrero Y., Calle M., Deleu L., Sommer C., Thomas N., Rommelaers J., Schlehofer J.R. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models. Neuro Oncol. 2010, 12:804-814.
21. Guetta E., Graziani Y., Tal J. Suppression of ehrlich ascites tumors in mice by minute virus of mice. J. Natl. Cancer Inst. 1986, 76:1177-1180.
22. Guetta E., Mincberg M., Mousset S., Bertinchamps C., Rommelaere J., Tal J. Selective killing of transformed rat cells by minute virus of mice does not require infectious virus production. J. Virol. 1990, 64:458-462.
23. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468.
24. Hahn W.C., Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2002, 2:331-341.
25. Hallauer C., Siegl G., Kronauer G. Parvoviruses as contaminants of permanent human cell lines. 3. Biological properties of the isolated viruses. Arch. Gesamte. Virusforsch. 1972, 38:366-382.
26. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 1967, 26:365-369.
27. Legrand C., Mousset S., Salome N., Rommelaere J. Cooperation of oncogenes in cell transformation and sensitization to killing by the parvovirus minute virus of mice. J. Gen. Virol. 1992, 73:2003-2009.
28. Maxwell I.H., Spitzer A.L., Maxwell F., Pintel D.J. The capsid determinant of fibrotropism for the MVMp strain of minute virus of mice functions via VP2 and not VP1. J. Virol. 1995, 69:5829-5832.
29. Maroto B., Valle N., Saffrich R., Almendral J.M. Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface. J. Virol. 2004, 78:10685-10694.
30. Mousset S., Ouadrhiri Y., Caillet-Fauquet P., Rommelaere J. The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J. Virol. 1994, 68:6446-6453.
31. Nam H.J., Gurda-Whitaker B., Gan W.Y., Ilaria S., McKenna R., Mehta P., Alvarez R.A., Agbandje-McKenna M. Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J. Biol. Chem. 2006, 281:25670-25677.
32. Previsani N., Fontana S., Hirt B., Beard P. Growth of the parvovirus minute virus of mice MVMp3 in EL4 lymphocytes is restricted after cell entry and before viral DNA amplification: cell-specific differences in virus uncoating in vitro. J. Virol. 1997, 71:7769-7780.
33. Raykov Z., Grekova S., Galabov A.S., Balboni G., Koch U., Aprahamian M., Rommelaere J. Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model. Oncol. Rep. 2007, 17:1493-1499.
34. Rommelaere J., Cornelis J.J. Antineoplastic activity of parvoviruses. J. Virol. Methods 1991, 33:233-251.
35. Ryder E.F., Robakiewicz P. Statistics for the molecular biologists: group comparisons. Curr. Protoc. Mol. Biol. 2001, A.3I.1-A.3I.22.
36. Shi Z.Y., Ma C.W., Huang J., Lin W.M., Dong R.C., Luo Z.Y. Inhibition of parvovirus H-1 on transplantable human hepatoma and its histological and histobiochemical studies. Shi Yan Sheng Wu Xue Bao 1997, 30:247-259.
37. Siegl G. The parvoviruses. Biology and pathogenicity of autonomous parvoviruses 1984, 297-362. Plenum Press, New York. K.I. Bern (Ed.).
38. Spalholz B.A., Tattersall P. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J. Virol. 1983, 46:937-943.
39. Tattersall P., Crawford L.V., Shatkin A.J. Replication of the parvovirus MVM. II. Isolation and characterization of intermediates in the replication of the viral deoxyribonucleic acid. J. Virol. 1973, 12:1446-1456.
40. Tattersall P., Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 1983, 46:944-955.
41. Tattersall P., Bergoin M., Bloom M.E., Brown K.E., Linden R.M., Muzyczka N., Parrish C.R., Tijssen P. Parvoviridae. Virus Taxonomy, VIIIth Report of the ICTV 2005, 593-608. Elsevier/Academic Press, London. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
42. Toolan H.W. Lack of oncogenic effect of the H-viruses for hamsters. Nature 1967, 214:1036.
43. Toolan H.W., Rhode S.L., Gierthy J.F. Inhibition of 7,12-dimethyl-benz(a)anthracene-induced tumors in syrian hamsters by prior infection with H-1 parvovirus. Cancer Res. 1982, 42:2552-2555.
44. Van Hille B., Duponchel N., Salome N., Spruyt N., Cotmore S.F., Tattersall P., Cornelis J.J., Rommelaere J. Limitations to the expression of parvoviral nonstructural proteins may determine the extent of sensitization of EJ-ras-transformed rat cells to minute virus of mice. Virology 1989, 171:89-97.
45. Van Vliet K.M., Blouin V., Brument N., Agbandje-McKenna M., Snyder R.O. The role of the adeno-associated virus capsid in gene transfer methods. Mol. Biol. 2008, 437:51-91.
46. Wrzesinski C., Tesfay L., Salome N., Jauniaux J.C., Rommelaere J., Cornelis J., Dinsart C. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells. J. Virol. 2003, 77:3851-3858.
47. Wu J.T., Byrne H.M., Kirn D.H., Wein L.M. Modeling and analysis of a virus that replicates selectively in tumor cells. Bull. Math. Biol. 2001, 63:731-768.